HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.

AbstractBACKGROUND & AIMS:
Prothrombin induced by vitamin K absence-II (PIVKA-II) is a diagnostic and surveillance marker for HCC mainly used in Asia, and has also been shown to be a predictor of microvascular invasion (MVI), a major prognostic factor in HCC. However, experience with PIVKA-II in Europe remains limited.
METHODS:
In a French cohort, we conducted a case-control study to compare the performances of α-fetoprotein (AFP) and PIVKA-II serum levels for diagnosis of early stage HCC, and we determined the value of PIVKA-II serum and tissue expression in pre-operative detection of MVI. 43 cirrhotic control patients and 85 HCC cases were included, of which 54 (63.5%) had early stage HCC (n=22 very early, n=32 early). PIVKA-II tissue expression was assessed by immunohistochemistry in HCC surgical samples.
RESULTS:
For the diagnosis of early HCC, PIVKA-II had a sensitivity of 77% and a specificity of 82% at a cut-off of 42 mAU/ml, vs. 61% and 50% for AFP at a cut-off of 5.5 ng/ml (AUC 0.81 vs. 0.58, respectively). A PIVKA-II level >90 mAU/ml was an independent predictor of MVI (HR 3.5; 95% CI 1.08-11.8; p=0.043). High PIVKA-II tissue expression was significantly associated with the presence of MVI (p=0.001). When combining PIVKA-II immunostaining with the PIVKA-II serum level, sensitivity and specificity for the diagnosis of MVI increased from 70% to 87% and 63% to 90%, respectively.
CONCLUSIONS:
PIVKA-II was more efficient than AFP for the diagnosis of early HCC, and could be used as a predictive biomarker of MVI.
AuthorsNicolas Poté, François Cauchy, Miguel Albuquerque, Hélène Voitot, Jacques Belghiti, Laurent Castera, Hervé Puy, Pierre Bedossa, Valérie Paradis
JournalJournal of hepatology (J Hepatol) Vol. 62 Issue 4 Pg. 848-54 (Apr 2015) ISSN: 1600-0641 [Electronic] Netherlands
PMID25450201 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Biomarkers
  • Biomarkers, Tumor
  • Protein Precursors
  • alpha-Fetoproteins
  • acarboxyprothrombin
  • Prothrombin
Topics
  • Adult
  • Aged
  • Biomarkers (blood, metabolism)
  • Biomarkers, Tumor (blood, metabolism)
  • Carcinoma, Hepatocellular (blood, pathology)
  • Case-Control Studies
  • Comparative Effectiveness Research
  • Early Detection of Cancer
  • Female
  • France
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms (blood, pathology)
  • Male
  • Middle Aged
  • Neoplasm Invasiveness (diagnosis)
  • Predictive Value of Tests
  • Prognosis
  • Protein Precursors (blood, metabolism)
  • Prothrombin (metabolism)
  • ROC Curve
  • Sensitivity and Specificity
  • alpha-Fetoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: